To gain insights into the positive role of SHP2 in melanoma cell viability, we examined the proliferation marker PCNA and apoptosis marker cleaved PARP after SHP2 overexpression or knockdown in MeWo cells (Figure 2B). The gene discussed is PCNA; the disease is melanoma.